MicroRNA-34 family, mechanisms of action in cancer: A review

Current Cancer Drug Targets

Volumn 14, Issue 8, 2014, Pages 737-751

  Maroof, Hamidreza ^a   Salajegheh, Ali ^a   Smith, Robert Anthony ^a   Lam, Alfred King Yin ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Cancer; Carcinoma; miR 34a; miR 34b; miR 34c; miRNA 34 family; Tumour suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BONE MORPHOGENETIC PROTEIN 2; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DOXORUBICIN; GENISTEIN; HERMES ANTIGEN; MICRORNA; MICRORNA 34; NOTCH RECEPTOR; PROTEIN BAX; PROTEIN MCL 1; PROTEIN P19; PROTEIN P21; PROTEIN P53; PUMA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIRTUIN 1; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL AGING; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; METASTASIS; METHYLATION; PATHOGENESIS; TUMOR INVASION; UPREGULATION; ANIMAL; CELL CYCLE; CELL MOTION; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HUMAN; NEOPLASM; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84919764246     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/1568009614666141020100337     Document Type: Article

References (147)

1. Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75, 843-854.
2. Ruvkun, G. Glimpses of a Tiny RNA World. Science, 2001, 294, 797-799.
3. Gopalan, V.; Pillai, S.; Ebrahimi, F.; Salajegheh, A.; Lam, T. C.; Le, T.K.; Langsford, N.; Ho, Y. H.; Smith, R. A.; Lam, A. K. Regulation of microRNA-1288 in colorectal cancer: Altered expression and its clinicopathological significance. Mol Carcinog., 2014, 53, E36-E44.
4. Ebrahimi, F.; Gopalan, V.; Smith, R. A.; Lam, A. K. miR-126 in human cancers: Clinical roles and current perspectives. Exp Mol Pathol., 2014, 96, 98-107.
5. Nelson, J. B.; Nabulsi, A. A.; Vogelzang, N. J.; Breul, J.; Zonnenberg, B. A.; Daliani, D. D.; Schulman, C. C.; Carducci, M. A. Suppression of prostate cancer induced bone remodeling by the endothelin receptor a antagonist Atrasentan. J. Urol., 2003, 169, 1143-1149.
6. Serpico, D.; Molino, L.; Di Cosimo, S. microRNAs in breast cancer development and treatment. Cancer Treat Rev., 2014, 40, 595-604.
7. Ruby, J. G.; Jan, C.; Player, C.; Axtell, M. J.; Lee, W.; Nusbaum, C.; Ge, H.; Bartel, D. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell, 2006, 127, 1193-1207.
8. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 2999-3004.
9. He, L.; He, X.; Lim, L. P.; de Stanchina, E.; Xuan, Z.; Liang, Y.; Xue, W.; Zender, L.; Magnus, J.; Ridzon, D.; Jackson, A. L.; Linsley, P. S.; Chen, C.; Lowe, S. W.; Cleary, M. A.; Hannon, G. J. A microRNA component of the p53 tumour suppressor network. Nature, 2007, 447, 1130-1134.
10. Bommer, G. T.; Gerin, I.; Feng, Y.; Kaczorowski, A. J.; Kuick, R.; Love, R. E.; Zhai, Y.; Giordano, T. J.; Qin, Z. S.; Moore, B. B.; MacDougald, O. A.; Cho, K. R.; Fearon, E. R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol., 2007, 17, 1298-1307.
11. Lodygin, D.; Tarasov, V.; Epanchintsev, A.; Berking, C.; Knyazeva, T.; Körner, H.; Knyazev, P.; Diebold, J.; Hermeking, H. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle, 2008, 7, 2591-2600.
12. Gallardo, E.; Navarro, A.; Vinolas, N.; Marrades, R. M.; Diaz, T.; Gel, B.; Quera, A.; Bandres, E.; Garcia-Foncillas, J.; Ramirez, J.; Monzo, M. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis, 2009, 30, 1903-1909.
13. Wiggins, J.F.; Ruffino, L.; Kelnar, K.; Omotola, M.; Patrawala, L.; Brown, D.; Bader, A. G. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res., 2010, 70, 5923-5930.
14. Chang, T.C.; Wentzel, E.A.; Kent, O.A.; Ramachandran, K.; Mullendore, M.; Lee, K.H.; Feldmann, G.; Yamakuchi, M.; Ferlito, M.; Lowenstein, C.J.; Arking, D.E.; Beer, M.A.; Maitra, A.; Mendell, J.T. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 2007, 26, 745-752.
15. Vogt, M.; Munding, J.; Gruner, M.; Liffers, S.T.; Verdoodt, B.; Hauk, J.; Steinstraesser, L.; Tannapfel, A.; Hermeking, H. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch., 2011, 458, 313-322.
16. Tazawa, H.; Tsuchiya, N.; Izumiya, M.; Nakagama, H. Tumorsuppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 15472-15477.
17. Fujita, Y.; Kojima, K.; Hamada, N.; Ohhashi, R.; Akao, Y.; Nozawa, Y.; Deguchi, T.; Ito, M. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem. Biophys. Res. Commun., 2008, 377, 114-119.
18. Li, N.; Fu, H.; Tie, Y.; Hu, Z.; Kong, W.; Wu, Y.; Zheng, X. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett., 2009, 275, 44-53.
19. Tryndyak, V.P.; Ross, S.A.; Beland, F.A.; Pogribny, I.P. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol. Carcinog., 2009, 48, 479-487.
20. Feinberg-Gorenshtein, G.; Avigad, S.; Jeison, M.; Halevy-Berco, G.; Mardoukh, J.; Luria, D.; Ash, S.; Steinberg, R.; Weizman, A.; Yaniv, I. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site. Genes Chromosomes Cancer, 2009, 48, 539-543.
21. Cole, K.A.; Attiyeh, E.F.; Mosse, Y.P.; Laquaglia, M.J.; Diskin, S.J.; Brodeur, G.M.; Maris, J.M. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res., 2008, 6, 735-742.
22. Wang, X.; Wang, H.K.; McCoy, J.P.; Banerjee, N.S.; Rader, J.S.; Broker, T. R.; Meyers, C.; Chow, L.T.; Zheng, Z.M. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA, 2009, 15, 637-647.
23. Li, B.; Hu, Y.; Ye, F.; Li, Y.; Lv, W.; Xie, X. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int. J. Gynecol. Cancer, 2010, 20, 597-604.
24. Chen, X.; Hu, H.; Guan, X.; Xiong, G.; Wang, Y.; Wang, K.; Bai, Y. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int. J. Cancer, 2012, 130, 1607-1613.
25. Mraz, M.; Malinova, K.; Kotaskova, J.; Pavlova, S.; Tichy, B.; Malcikova, J.; Stano Kozubik, K.; Smardova, J.; Brychtova, Y.; Doubek, M.; Trbusek, M.; Mayer, J.; Pospisilova, S. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia, 2009, 23, 1159-1163.
26. Chim, C.S.; Wong, K.Y.; Qi, Y.; Loong, F.; Lam, W.L.; Wong, L.G.; Jin, D. Y.; Costello, J.F.; Liang, R. Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis, 2010, 31, 745-750.
27. Craig, V.J.; Cogliatti, S.B.; Imig, J.; Renner, C.; Neuenschwander, S.; Rehrauer, H.; Schlapbach, R.; Dirnhofer, S.; Tzankov, A.; Müller, A. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood, 2011, 117, 6227-6236.
28. Li, W.B.; Ma, M.W.; Dong, L.J.; Wang, F.; Chen, L.X.; Li, X.R. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol. Ther., 2011, 12, 477-483.
29. Welch, C.; Chen, Y.; Stallings, R.L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene, 2007, 26, 5017-5022.
30. Yan, D.; Zhou, X.; Chen, X.; Hu, D.N.; Dong, X.D.; Wang, J.; Lu, F.; Tu, L.; Qu, J. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest. Ophthalmol. Vis. Sci., 2009, 50, 1559-1565.
31. Greenberg, E.; Hershkovitz, L.; Itzhaki, O.; Hajdu, S.; Nemlich, Y.; Ortenberg, R.; Gefen, N.; Edry, L.; Modai, S.; Keisari, Y.; Besser, M.J.; Schachter, J.; Shomron, N.; Markel, G. Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One, 2011, 6, e18936.
32. Tarasov, V.; Jung, P.; Verdoodt, B.; Lodygin, D.; Epanchintsev, A.; Menssen, A.; Meister, G.; Hermeking, H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 2007, 6, 1586-1593.
33. Yan, K.; Gao, J.; Yang, T.; Ma, Q.; Qiu, X.; Fan, Q.; Ma, B. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One, 2012, 7, e33778.
34. Asslaber, D.; Pinon, J.D.; Seyfried, I.; Desch, P.; Stocher, M.; Tinhofer, I.; Egle, A.; Merkel, O.; Greil, R. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood, 2010, 115, 4191-4197.
35. Koufaris, C.; Wright, J.; Currie, R.A.; Gooderham, N.J. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. Toxicol Sci., 2012, 128, 532-543.
36. Audrito, V.; Vaisitti, T.; Rossi, D.; Gottardi, D.; D'Arena, G.; Laurenti, L.; Gaidano, G.; Malavasi, F.; Deaglio, S. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Res., 2011, 71, 4473-4483.
37. Pramanik, D.; Campbell, N.R.; Karikari, C.; Chivukula, R.; Kent, O.A.; Mendell, J.T.; Maitra, A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther., 2011, 10, 1470-1480.
38. Nalls, D.; Tang, S.N.; Rodova, M.; Srivastava, R.K.; Shankar, S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One, 2011, 6, e24099.
39. Wang, X.; Dong, K.; Gao, P.; Long, M.; Lin, F.; Weng, Y.; Ouyang, Y.; Ren, J.; Zhang, H. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status. Cancer Biother Radiopharm., 2013, 28, 45-50.
40. Kumar, B.; Yadav, A.; Lang, J.; Teknos, T.N.; Kumar, P. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS One, 2012, 7, e37601.
41. Pulikkan, J.A.; Peramangalam, P.S.; Dengler, V.; Ho, P.A.; Preudhomme, C.; Meshinchi, S.; Christopeit, M.; Nibourel, O.; Müller-Tidow, C.; Bohlander, S. K.; Tenen, D.G.; Behre, G. C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood, 2010, 116, 5638-5649.
42. Li, Y.; Guessous, F.; Zhang, Y.; Dipierro, C.; Kefas, B.; Johnson, E.; Marcinkiewicz, L.; Jiang, J.; Yang, Y.; Schmittgen, T.D.; Lopes, B.; Schiff, D.; Purow, B.; Abounader, R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res., 2009, 69, 7569-7576.
43. Wang, L.G.; Ni, Y.; Su, B.H.; Mu, X.R.; Shen, H.C.; Du, J.J. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int. J. Oncol., 2013, 42, 957-962.
44. Kasinski, A.L.; Slack, F.J. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res., 2012, 72, 5576-5587.
45. Corney, D.C.; Flesken-Nikitin, A.; Godwin, A.K.; Wang, W.; Nikitin, A.Y. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesionindependent growth. Cancer Res., 2007, 67, 8433-8438.
46. Antonini, D.; Russo, M.T.; De Rosa, L.; Gorrese, M.; Del Vecchio, L.; Missero, C. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J. Invest. Dermatol., 2010, 130, 1249-1257.
47. Silber, J.; Jacobsen, A.; Ozawa, T.; Harinath, G.; Pedraza, A.; Sander, C.; Holland, E.C.; Huse, J.T. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One, 2012, 7, e33844.
48. Ramaiah, M.J.; Pushpavalli, S.N.; Lavanya, A.; Bhadra, K.; Haritha, V.; Patel, N.; Tamboli, J.R.; Kamal, A.; Bhadra, U.; Pal-Bhadra, M. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis. Bioorg. Med. Chem. Lett., 2013, 23, 5699-5706.
49. Corney, D.C.; Hwang, C.I.; Matoso, A.; Vogt, M.; Flesken-Nikitin, A.; Godwin, A.K.; Kamat, A.A.; Sood, A.K.; Ellenson, L.H.; Hermeking, H.; Nikitin, A.Y. Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res., 2010, 16, 1119-1128.
50. Bae, Y.; Yang, T.; Zeng, H.C.; Campeau, P.M.; Chen, Y.; Bertin, T.; Dawson, B.C.; Munivez, E.; Tao, J.; Lee, B.H. miRNA-34c regulates Notch signaling during bone development. Hum. Mol. Genet., 2012, 21, 2991-3000.
51. Concepcion, C.P.; Han, Y.C.; Mu, P.; Bonetti, C.; Yao, E.; D'Andrea, A.; Vidigal, J.A.; Maughan, W.P.; Ogrodowski, P.; Ventura, A. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet., 2012, 8, e1002797.
52. Iqbal, N.; Mei, J.; Liu, J.; Skapek, S.X. miR-34a is essential for p19-driven cell cycle arrest. Cell Cycle, 2014, 13, 792-800.
53. Tanaka, N.; Toyooka, S.; Soh, J.; Tsukuda, K.; Shien, K.; Furukawa, M.; Muraoka, T.; Maki, Y.; Ueno, T.; Yamamoto, H.; Asano, H.; Otsuki, T.; Miyoshi, S. Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells. Oncol. Rep., 2013, 29, 2169-2174.
54. Nugent, M.; Miller, N.; Kerin, M.J. Circulating miR-34a levels are reduced in colorectal cancer. J. Surg. Oncol., 2012, 106, 947-952.
55. Ji, Q.; Hao, X.; Zhang, M.; Tang, W.; Yang, M.; Li, L.; Xiang, D.; Desano, J. T.; Bommer, G.T.; Fan, D.; Fearon, E.R.; Lawrence, T.S.; Xu, L. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One, 2009, 4, e6816.
56. Kent, O.A.; Mullendore, M.; Wentzel, E.A.; Lopez-Romero, P.; Tan, A.C.; Alvarez, H.; West, K.; Ochs, M.F.; Hidalgo, M.; Arking, D.E.; Maitra, A.; Mendell, J.T. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol. Ther., 2009, 8, 2013-2024.
57. Xia, J.; Duan, Q.; Ahmad, A.; Bao, B.; Banerjee, S.; Shi, Y.; Ma, J.; Geng, J.; Chen, Z.; Rahman, K.M.; Miele, L.; Sarkar, F.H.; Wang, Z. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr. Drug Targets, 2012, 13, 1750-1756.
58. Kashat, M.; Azzouz, L.; Sarkar, S.H.; Kong, D.; Li, Y.; Sarkar, F.H. Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. Am. J. Transl. Res., 2012, 4, 432-442.
59. Kong, D.; Heath, E.; Chen, W.; Cher, M.; Powell, I.; Heilbrun, L.; Li, Y.; Ali, S.; Sethi, S.; Hassan, O.; Hwang, C.; Gupta, N.; Chitale, D.; Sakr, W.A.; Menon, M.; Sarkar, F.H. Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. Am. J. Transl. Res., 2012, 4, 14-23.
60. Li, L.; Xie, X.; Luo, J.; Liu, M.; Xi, S.; Guo, J.; Xie, Z.; Tang, J.; Wang, X.; Wei, W.; Yang, M.; Hung, M.C.; Xie, X. Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion. Mol. Ther., 2012, 20, 2326-2334.
61. Tanaka, N.; Toyooka, S.; Soh, J.; Kubo, T.; Yamamoto, H.; Maki, Y.; Muraoka, T.; Shien, K.; Furukawa, M.; Ueno, T.; Asano, H.; Tsukuda, K.; Aoe, K.; Miyoshi, S. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer, 2012,76, 32-38.
62. Ji, X.; Wang, Z.; Geamanu, A.; Goja, A.; Sarkar, F.H.; Gupta, S.V. Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells. Int. J. Cancer, 2012, 131, 2668-2677.
63. Ji, Q.; Hao, X.; Meng, Y.; Zhang, M.; Desano, J.; Fan, D.; Xu, L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer, 2008, 8, 266.
64. Roy, S.; Levi, E.; Majumdar, A.P.; Sarkar, F.H. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF. J. Hematol. Oncol., 2012, 5, 58.
65. Watahiki, A.; Wang, Y.; Morris, J.; Dennis, K.; O'Dwyer, H.M.; Gleave, M.; Gout, P.W.; Wang, Y. MicroRNAs associated with metastatic prostate cancer. PLoS One, 2011, 6, e24950.
66. Javeri, A.; Ghaffarpour, M.; Taha, M.F.; Houshmand, M. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Med. Oncol., 2013, 30, 413.
67. Ahn, Y.H.; Gibbons, D.L.; Chakravarti, D.; Creighton, C.J.; Rizvi, Z.H.; Adams, H.P.; Pertsemlidis, A.; Gregory, P.A.; Wright, J.A.; Goodall, G.J.; Flores, E.R.; Kurie, J.M. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J. Clin. Invest., 2012, 122, 3170-3183.
68. Wu, J.; Wu, G.; Lv, L.; Ren, Y.F.; Zhang, X.J.; Xue, Y.F.; Li, G.; Lu, X.; Sun, Z.; Tang, K.F. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis, 2012, 33, 519-528.
69. Pang, R.T.; Leung, C.O.; Ye, T.M.; Liu, W.; Chiu, P.C.; Lam, K.K.; Lee, K.F.; Yeung, W.S. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis, 2010, 31, 1037-1044.
70. Dalerba, P.; Dylla, S.J.; Park, I.K.; Liu, R.; Wang, X.; Cho, R.W.; Hoey, T.; Gurney, A.; Huang, E.H.; Simeone, D.M.; Shelton, A.A.; Parmiani, G.; Castelli, C.; Clarke, M.F. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 10158-10163.
71. Prince, M.E.; Sivanandan, R.; Kaczorowski, A.; Wolf, G.T.; Kaplan, M.J.; Dalerba, P.; Weissman, I.L.; Clarke, M.F.; Ailles, L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 973-978.
72. Zhang, S.; Balch, C.; Chan, M.W.; Lai, H.C.; Matei, D.; Schilder, J.M.; Yan, P. S.; Huang, T.H.; Nephew, K.P. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res., 2008, 68, 4311-4320.
73. Yang, Z.F.; Ho, D.W.; Ng, M.N.; Lau, C.K.; Yu, W.C.; Ngai, P.; Chu, P.W.; Lam, C.T.; Poon, R.T.; Fan, S.T. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell, 2008, 13, 153-166.
74. Takaishi, S.; Okumura, T.; Tu, S.; Wang, S.S.; Shibata, W.; Vigneshwaran, R.; Gordon, S.A.; Shimada, Y.; Wang, T.C. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells, 2009, 27, 1006-1020.
75. Chan, K.S.; Espinosa, I.; Chao, M.; Wong, D.; Ailles, L.; Diehn, M.; Gill, H.; Presti, J. Jr.; Chang, H.Y.; van de Rijn, M.; Shortliffe, L.; Weissman, I.L. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 14016-14021.
76. Liu, C.; Kelnar, K.; Liu, B.; Chen, X.; Calhoun-Davis, T.; Li, H.; Patrawala, L.; Yan, H.; Jeter, C.; Honorio, S.; Wiggins, J.F.; Bader, A.G.; Fagin, R.; Brown, D.; Tang, D. G. Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44. Nat. Med., 2011, 17, 211-215.
77. Beltran, A.S.; Russo, A.; Lara, H.; Fan, C.; Lizardi, P.M.; Blancafort, P. Suppression of breast tumor growth and metastasis by an engineered transcription factor. PLoS One, 2011, 6, e24595.
78. Cheng, J.; Zhou, L.; Xie, Q.F.; Xie, H.Y.; Wei, X.Y.; Gao, F.; Xing, C.Y.; Xu, X.; Li, L.J.; Zheng, S. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells. Proteomics, 2010, 10, 1557-1572.
79. Siemens, H.; Jackstadt, R.; Hunten, S.; Kaller, M.; Menssen, A.; Gotz, U.; Hermeking, H. miR-34 and SNAIL form a doublenegative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle, 2011, 10, 4256-4271.
80. Mudduluru, G.; Ceppi, P.; Kumarswamy, R.; Scagliotti, G.V.; Papotti, M.; Allgayer, H. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene, 2011, 30, 2888-2899.
81. Pogribny, I.P.; Tryndyak, V.P.; Boyko, A.; Rodriguez-Juarez, R.; Beland, F. A.; Kovalchuk, O. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat. Res., 2007, 619, 30-37.
82. Kim, N.H.; Kim, H.S.; Li, X.Y.; Lee, I.; Choi, H.S.; Kang, S.E.; Cha, S.Y.; Ryu, J.K.; Yoon, D.; Fearon, E. R.; Rowe, R.G.; Lee, S.; Maher, C.A.; Weiss, S.J.; Yook, J.I. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol., 2011, 195, 417-433.
83. Rokavec, M.; Oner, M.G.; Li, H.; Jackstadt, R.; Jiang, L.; Lodygin, D.; Kaller, M.; Horst, D.; Ziegler, P.K.; Schwitalla, S.; Slotta-Huspenina, J.; Bader, F.G.; Greten, F.R.; Hermeking, H. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J. Clin. Invest., 2014, 124, 1853-1867.
84. Hwang, C.I.; Matoso, A.; Corney, D.C.; Flesken-Nikitin, A.; Korner, S.; Wang, W.; Boccaccio, C.; Thorgeirsson, S.S.; Comoglio, P.M.; Hermeking, H.; Nikitin, A.Y. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 14240-14245.
85. Yamamura, S.; Saini, S.; Majid, S.; Hirata, H.; Ueno, K.; Chang, I.; Tanaka, Y.; Gupta, A.; Dahiya, R. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis, 2012, 33, 294-300.
86. Zenz, T.; Mohr, J.; Eldering, E.; Kater, A.P.; Buhler, A.; Kienle, D.; Winkler, D.; Dürig, J.; van Oers, M.H.; Mertens, D.; Döhner, H.; Stilgenbauer, S. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood, 2009, 113, 3801-3808.
87. Hau, A.; Ceppi, P.; Peter, M.E. CD95 is part of a let-7/p53/miR-34 regulatory network. PLoS One, 2012, 7, e49636.
88. He, C.; Xiong, J.; Xu, X.; Lu, W.; Liu, L.; Xiao, D.; Wang, D. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem. Biophys. Res. Commun., 2009, 388, 35-40.
89. Hui, C.; Yujie, F.; Lijia, Y.; Long, Y.; Hongxia, X.; Yong, Z.; Jundong, Z.; Qianyong, Z.; Mantian, M. MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis. Breast Cancer Res., 2012, 14, R80.
90. Wang, B.D.; Kline, C.L.; Pastor, D.M.; Olson, T.L.; Frank, B.; Luu, T.; Sharma, A.K.; Robertson, G.; Weirauch, M.T.; Patierno, S.R.; Stuart, J.M.; Irby, R.B.; Lee, N.H. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network. Mol. Cancer, 2010, 9, 98.
91. Ebner, O.A.; Selbach, M. Quantitative proteomic analysis of gene regulation by miR-34a and miR-34c. PLoS One, 2014, 9, e92166.
92. Merkel, O.; Asslaber, D.; Pinon, J.D.; Egle, A.; Greil, R. Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia. Cell Cycle, 2010, 9, 2764-2768.
93. Yamakuchi, M.; Ferlito, M.; Lowenstein, C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 13421-13426.
94. Kastl, L.; Brown, I.; Schofield, A.C. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res. Treat., 2012, 131, 445-454.
95. Garofalo, M.; Jeon, Y.J.; Nuovo, G.J.; Middleton, J.; Secchiero, P.; Joshi, P.; Alder, H.; Nazaryan, N.; Di Leva, G.; Romano, G.; Crawford, M.; Nana-Sinkam, P.; Croce, C.M. MiR-34a/c-Dependent PDGFR-alpha/beta downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS One, 2013, 8, e67581.
96. Soni, K.; Gupta, S.; Gokhale, S.S.; Dey, R.; Gunjal, A.D.; Kumar, V.A.; Pillai, B. Detection and knockdown of microRNA-34a using thioacetamido nucleic acid. Nucleic Acid Ther., 2013, 23, 195-202.
97. Balca-Silva, J.; Sousa Neves, S.; Goncalves, A.C.; Abrantes, A.M.; Casalta-Lopes, J.; Botelho, M.F.; Sarmento-Ribeiro, A.B.; Silva, H.C. Effect of miR-34b overexpression on the radiosensitivity of nonsmall cell lung cancer cell lines. Anticancer Res., 2012, 32, 1603-1609.
98. Dalgard, C.L.; Gonzalez, M.; deNiro, J.E.; O'Brien, J.M. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. Invest. Ophthalmol. Vis. Sci., 2009, 50, 4542-4551.
99. Hu, Q.L.; Jiang, Q.Y.; Jin, X.; Shen, J.; Wang, K.; Li, Y.B.; Xu, F.J.; Tang, G. P.; Li, Z.H. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model. Biomaterials, 2013, 34, 2265-2276.
100. Kovalchuk, O.; Filkowski, J.; Meservy, J.; Ilnytskyy, Y.; Tryndyak, V.P.; Chekhun, V.F.; Pogribny, I.P. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol. Cancer Ther., 2008, 7, 2152-2159.
101. Rudolf, E.; Rudolf, K.; Cervinka, M. Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells. Apoptosis, 2011, 16, 1165-1176.
102. Sarveswaran, S.; Liroff, J.; Zhou, Z.; Nikitin, A.Y.; Ghosh, J. Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer. Int. J. Oncol., 2010, 36, 1419-1428.
103. Niederer, F.; Trenkmann, M.; Ospelt, C.; Karouzakis, E.; Neidhart, M.; Stanczyk, J.; Kolling, C.; Gay, R.E.; Detmar, M.; Gay, S.; Jüngel, A.; Kyburz, D. Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis Rheum., 2012, 64, 1771-1779.
104. Iekushi, K.; Seeger, F.; Assmus, B.; Zeiher, A.M.; Dimmeler, S. Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction. Circulation, 2012, 125, 1765-1773.
105. Bouhallier, F.; Allioli, N.; Lavial, F.; Chalmel, F.; Perrard, M.H.; Durand, P.; Samarut, J.; Pain, B.; Rouault, J.P. Role of miR-34c microRNA in the late steps of spermatogenesis. RNA, 2010, 16, 720-731.
106. Bandi, N.; Vassella, E. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol. Cancer, 2011, 10, 55.
107. Bu, P.; Chen, K.Y.; Chen, J.H.; Wang, L.; Walters, J.; Shin, Y.J.; Goerger, J.P.; Sun, J.; Witherspoon, M.; Rakhilin, N.; Li, J.; Yang, H.; Milsom, J.; Lee, S.; Zipfel, W.; Jin, M.M.; Gümüş, Z.H.; Lipkin, S.M.; Shen, X. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell, 2013, 12, 602-615.
108. Cheng, C.Y.; Hwang, C.I.; Corney, D.C.; Flesken-Nikitin, A.; Jiang, L.; Oner, G.M.; Munroe, R.J.; Schimenti, J.C.; Hermeking, H.; Nikitin, A.Y. miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment. Cell Rep., 2014, 6, 1000-1007.
109. Zhao, J.; Lammers, P.; Torrance, C.J.; Bader, A.G. TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.). Mol. Ther., 2013, 21, 1678-1686.
110. Chen, H.C.; Chen, G.H.; Chen, Y.H.; Liao, W.L.; Liu, C.Y.; Chang, K. P.; Chang, Y.S.; Chen, S.J. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer, 2009, 100, 1002-1011.
111. Zovoilis, A.; Agbemenyah, H.Y.; Agis-Balboa, R.C.; Stilling, R.M.; Edbauer, D.; Rao, P.; Farinelli, L.; Delalle, I.; Schmitt, A.; Falkai, P.; Bahari-Javan, S.; Burkhardt, S.; Sananbenesi, F.; Fischer, A. microRNA-34c is a novel target to treat dementias. EMBO J., 2011, 30, 4299-4308.
112. Kumamoto, K.; Spillare, E.A.; Fujita, K.; Horikawa, I.; Yamashita, T.; Appella, E.; Nagashima, M.; Takenoshita, S.; Yokota, J.; Harris, C.C. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Res., 2008, 68, 3193-3203.
113. Christoffersen, N.R.; Shalgi, R.; Frankel, L.B.; Leucci, E.; Lees, M.; Klausen, M.; Pilpel, Y.; Nielsen, F.C.; Oren, M.; Lund, A.H. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ., 2010, 17, 236-245.
114. Yamakuchi, M.; Lowenstein, C.J. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle, 2009, 8, 712-715.
115. Zhang, Q.; Liu, H.; McGee, J.; Walsh, E.J.; Soukup, G.A.; He, D.Z. Identifying microRNAs involved in degeneration of the organ of corti during age-related hearing loss. PLoS One, 2013, 8, e62786.
116. Liu, N.; Landreh, M.; Cao, K.; Abe, M.; Hendriks, G.J.; Kennerdell, J.R.; Zhu, Y.; Wang, L.S.; Bonini, N.M. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature, 2012, 482, 519-523.
117. Yang, J.; Chen, D.; He, Y.; Melendez, A.; Feng, Z.; Hong, Q.; Bai, X.; Li, Q.; Cai, G.; Wang, J.; Chen, X. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age (Dordr.), 2013,35,11-22.
118. Ito, T.; Yagi, S.; Yamakuchi, M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun., 2010, 398, 735-740.
119. Sun, F.; Fu, H.; Liu, Q.; Tie, Y.; Zhu, J.; Xing, R.; Sun, Z.; Zheng, X. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett., 2008, 582, 1564-1568.
120. Markey, M.; Berberich, S.J. Full-length hdmX transcripts decrease following genotoxic stress. Oncogene, 2008, 27, 6657-6666.
121. Miller, K.R.; Kelley, K.; Tuttle, R.; Berberich, S.J. HdmX overexpression inhibits oncogene induced cellular senescence. Cell Cycle, 2010, 9, 3376-3382.
122. Yu, F.; Jiao, Y.; Zhu, Y.; Wang, Y.; Zhu, J.; Cui, X.; Liu, Y.; He, Y.; Park, E.Y.; Zhang, H.; Lv, X.; Ma, K.; Su, F.; Park, J.H.; Song, E. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells. J. Biol. Chem., 2012, 287, 465-473.
123. Yin, D.; Ogawa, S.; Kawamata, N.; Leiter, A.; Ham, M.; Li, D.; Doan, N.B.; Said, J.W.; Black, K.L.; Phillip Koeffler,H. miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene, 2013, 32, 1155-1163.
124. Chang, S.J.; Weng, S.L.; Hsieh, J.Y.; Wang, T.Y.; Chang, M.D.; Wang, H.W. MicroRNA-34a modulates genes involved in cellular motility and oxidative phosphorylation in neural precursors derived from human umbilical cord mesenchymal stem cells. BMC Med. Genomics, 2011, 4, 65.
125. Siemens, H.; Jackstadt, R.; Kaller, M.; Hermeking, H. Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget, 2013, 4, 1399-1415.
126. Kim, D.; Song, J.; Kim, S.; Chun, C.H.; Jin, E.J. MicroRNA-34a regulates migration of chondroblast and IL-1beta-induced degeneration of chondrocytes by targeting EphA5. Biochem. Biophys. Res. Commun., 2011, 415, 551-557.
127. Chong, J.L.; Tsai, S.Y.; Sharma, N.; Opavsky, R.; Price, R.; Wu, L.; Fernandez, S.A.; Leone, G. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol. Cell Biol., 2009, 29, 414-424.
128. Asp, P.; Acosta-Alvear, D.; Tsikitis, M.; van Oevelen, C.; Dynlacht, B.D. E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation. Genes Dev., 2009, 23, 37-53.
129. Danielian, P.; Friesenhahn, L.; Faust, A.; West, J.; Caron, A.; Bronson, R.; Lees, J.A. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity. Oncogene, 2008, 27, 6561-6570.
130. Chen, C.; Wells, A.D. Comparative analysis of E2F family member oncogenic activity. PLoS One, 2007, 2, e912.
131. Kawasaki, H.; Toyoda, M.; Shinohara, H.; Okuda, J.; Watanabe, I.; Yamamoto, T.; Tanaka, K.; Tenjo, T.; Tanigawa, N. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer, 2001, 91, 2026-2032.
132. Lam, A.K.; Saleh, S.; Smith, R.A.; Ho, Y.H. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Hum Pathol., 2008, 39, 1229-1233.
133. Su, L.; Wang, Y.; Xiao, M.; Lin, Y.; Yu, L. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110, 484-491.
134. Tanaka, K.; Iwamoto, S.; Gon, G.; Nohara, T.; Iwamoto, M.; Tanigawa, N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res., 2000, 6, 127-134.
135. Tran, J.; Master, Z.; Yu, J.L.; Rak, J.; Dumont, D.J.; Kerbel, R.S. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 4349-4354.
136. Swana, H.S.; Grossman, D.; Anthony, J.N.; Weiss, R.M.; Altieri, D.C. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N. Engl. J. Med., 1999, 341, 452-453.
137. Bernardo, B.C.; Gao, X.M.; Winbanks, C.E.; Boey, E.J.; Tham, Y.K.; Kiriazis, H.; Gregorevic, P.; Obad, S.; Kauppinen, S.; Du, X.J.; Lin, R.C.; McMullen, J.R. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 17615-17620.
138. Caporali, A.; Emanueli, C. MicroRNA regulation in angiogenesis. Vascul. Pharmacol., 2011, 55, 79-86.
139. Zhao, T.; Li, J.; Chen, A.F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab., 2010, 299, E110-6.
140. Menghini, R.; Casagrande, V.; Cardellini, M.; Martelli, E.; Terrinoni, A.; Amati, F.; Vasa-Nicotera, M.; Ippoliti, A.; Novelli, G.; Melino, G.; Lauro, R.; Federici, M. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation, 2009, 120, 1524-1532.
141. Xu, Q.; Seeger, F.H.; Castillo, J.; Iekushi, K.; Boon, R.A.; Farcas, R.; Manavski, Y.; Li, Y.G.; Assmus, B.; Zeiher, A.M.; Dimmeler, S. Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J. Am. Coll. Cardiol., 2012, 59, 2107-2117.
142. Cannell, I.G.; Bushell, M. Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? Cell Cycle, 2010, 9, 2726-2730.
143. Kong, D.; Heath, E.; Chen, W.; Cher, M.; Powell, I.; Heilbrun, L.; Li, Y.; Ali, S.; Sethi, S.; Hassan, O.; Hwang, C.; Gupta, N.; Chitale, D.; Sakr, W.; Menon, M.; Sarkar, F. Erratum: Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. Am. J. Transl. Res., 2013, 6,102-103.
144. Wang, Z.; Chen, Z.; Gao, Y.; Li, N.; Li, B.; Tan, F.; Tan, X.; Lu, N.; Sun, Y.; Sun, J.; Sun, N.; He, J. DNA hypermethylation of microRNA-34b/c has prognostic value for stage non-small cell lung cancer. Cancer Biol. Ther., 2011, 11, 490-496.
145. Wong, K.Y.; Yim, R.L.; So, C.C.; Jin, D.Y.; Liang, R.; Chim, C.S. Epigenetic inactivation of the MIR34B/C in multiple myeloma. Blood, 2011, 118, 5901-5904.
146. Toyota, M.; Suzuki, H.; Sasaki, Y.; Maruyama, R.; Imai, K.; Shinomura, Y.; Tokino, T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res., 2008, 68, 4123-4132.
147. Siemens, H.; Neumann, J.; Jackstadt, R.; Mansmann, U.; Horst, D.; Kirchner, T.; Hermeking, H.Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and beta-catenin predicts distant metastasis of colon cancer. Clin. Cancer Res., 2013, 19, 710-720.